{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:17:24Z","timestamp":1778566644925,"version":"3.51.4"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Cardiogenic shock (CS) is a life-threatening condition with high mortality. Temporary mechanical circulatory support (tMCS) is important for stabilizing patients with refractory CS, acting as a bridge to recovery, decision-making for durable left ventricular assist device (LVAD) implantation or transplantation. In China, commonly used devices like intra-aortic balloon pumps (IABP) and extracorporeal membrane oxygenation (ECMO) have limitations such as inadequate ventricular unloading and high complication rates, and advanced options like Impella, TandemHeart and CentriMag are not widely available. This report presents a successful bridge to durable LVAD therapy case using a minimally invasive extracorporeal VAD in a high-risk CS patient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>A 39-year-old male with refractory cardiogenic shock due to ischemic cardiomyopathy is reported. He was not a candidate for immediate durable LVAD implantation or transplantation because of unstable hemodynamics, severe pulmonary edema, and active infection. Considering his condition, a percutaneous extracorporeal VAD was inserted through the right axillary artery and jugular vein, creating a bypass from the left atrium \u2192 across the atrial septum \u2192 right atrium \u2192 superior vena cava \u2192 right jugular vein \u2192 centrifugal pump \u2192 axillary artery. The operation was carried out without any complications, and the patient quickly improved. After 215\u2005h and 43\u2005min of support, he successfully received durable LVAD implantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This case demonstrates the clinical value of a minimally invasive extracorporeal VAD as a bridge-to-bridge therapy for critical cardiogenic shock. The percutaneous approach effectively unloads the left ventricle while minimizing complications. It promotes early patient mobilization, simplifies postoperative care, and lowers treatment costs. This method is technically simple and controllable in most hospital environments, offering practical guidance for managing high-risk shock patients, especially in places where advanced surgical options are restricted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1720250","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:44:36Z","timestamp":1778564676000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Percutaneous extracorporeal ventricular assist device as a successful bridge strategy to durable left ventricular assist device in refractory cardiogenic shock: a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Dan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University","place":["Wuhan, Hubei, China"]},{"name":"Department of Cardiovascular Surgery, Hubei Provincial Engineering Research Center of Minimally Invasive Cardiovascular Surgery","place":["Wuhan, Hubei, China"]},{"name":"Department of Cardiovascular Surgery, Wuhan Clinical Research Center for Minimally Invasive Treatment of Structural Heart Disease","place":["Wuhan, Hubei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University","place":["Wuhan, Hubei, China"]},{"name":"Department of Cardiovascular Surgery, Hubei Provincial Engineering Research Center of Minimally Invasive Cardiovascular Surgery","place":["Wuhan, Hubei, China"]},{"name":"Department of Cardiovascular Surgery, Wuhan Clinical Research Center for Minimally Invasive Treatment of Structural Heart Disease","place":["Wuhan, Hubei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinping","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University","place":["Wuhan, Hubei, China"]},{"name":"Department of Cardiovascular Surgery, Hubei Provincial Engineering Research Center of Minimally Invasive Cardiovascular Surgery","place":["Wuhan, Hubei, China"]},{"name":"Department of Cardiovascular Surgery, Wuhan Clinical Research Center for Minimally Invasive Treatment of Structural Heart Disease","place":["Wuhan, Hubei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinping","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University","place":["Wuhan, Hubei, China"]},{"name":"Department of Cardiovascular Surgery, Hubei Provincial Engineering Research Center of Minimally Invasive Cardiovascular Surgery","place":["Wuhan, Hubei, China"]},{"name":"Department of Cardiovascular Surgery, Wuhan Clinical Research Center for Minimally Invasive Treatment of Structural Heart Disease","place":["Wuhan, Hubei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.jacc.2025.02.018","article-title":"2025 Concise clinical guidance: an ACC expert consensus statement on the evaluation and management of cardiogenic shock: a report of the American College of Cardiology solution set oversight committee","volume":"85","author":"Sinha","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.21037\/acs.2018.12.01","article-title":"Temporary mechanical circulatory support for refractory heart failure: the German Heart Center Berlin experience","volume":"8","author":"Nersesian","year":"2019","journal-title":"Ann Cardiothorac Surg"},{"key":"B3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0140-6736(20)31047-3","article-title":"Temporary circulatory support for cardiogenic shock","volume":"396","author":"Combes","year":"2020","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.metabol.2017.01.009","article-title":"Mechanical circulatory support for end-stage heart failure","author":"Combes","year":"2017","journal-title":"Metab Clin Exp"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1093\/eurheartj\/ehae925","article-title":"Mechanical circulatory support: when, how, and for whom","volume":"46","author":"M\u00f8ller","year":"2025","journal-title":"Eur Heart J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1161\/CIRCHEARTFAILURE.113.000271","article-title":"Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes","volume":"7","author":"Takayama","year":"2014","journal-title":"Circ Heart Fail"},{"key":"B7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.athoracsur.2016.06.002","article-title":"Outcomes of patients receiving temporary circulatory support before durable ventricular assist device","volume":"103","author":"Shah","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1002\/ehf2.13769","article-title":"First experience of magnetically levitated extracorporeal left ventricular assist device for cardiogenic shock in China","volume":"9","author":"Li","year":"2022","journal-title":"ESC Heart Fail"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.cardfail.2021.08.010","article-title":"Heart failure-related cardiogenic shock: pathophysiology, evaluation and management considerations","volume":"27","author":"Abraham","year":"2021","journal-title":"J Card Fail"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1161\/CIR.0000000000001076","article-title":"Escalating and De-escalating temporary mechanical circulatory support in cardiogenic shock: a scientific statement from the American Heart Association","volume":"146","author":"Geller","year":"2022","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jcin.2021.02.046","article-title":"Mechanical circulatory support as a bridge to definitive treatment in post-infarction ventricular septal rupture","volume":"14","author":"Ronco","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e019376","DOI":"10.1161\/JAHA.120.019376","article-title":"Intra-Aortic balloon pump as a bridge to durable left ventricular assist device","volume":"10","author":"Brown","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B13","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.pcad.2020.07.001","article-title":"Intra-aortic balloon counterpulsation - does it work?","volume":"63","author":"Freund","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/icvts\/ivy185","article-title":"Comparison of temporary ventricular assist devices and extracorporeal life support in post-cardiotomy cardiogenic shock","volume":"27","author":"Mohite","year":"2018","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41569-022-00796-5","article-title":"Temporary mechanical circulatory support devices: practical considerations for all stakeholders","volume":"20","author":"Salter","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1111\/jocs.15552","article-title":"Thoracotomy versus sternotomy? The effect of surgical approach on outcomes after left ventricular assist device implantation: a review of the literature and meta-analysis","volume":"36","author":"Worku","year":"2021","journal-title":"J Card Surg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"100008","DOI":"10.1016\/j.jscai.2021.100008","article-title":"SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies: this statement was endorsed by the American College of Cardiology (ACC), American college of emergency physicians (ACEP), American Heart Association (AHA), European society of cardiology (ESC) association for acute cardiovascular care (ACVC), international society for heart and lung transplantation (ISHLT), society of critical care medicine (SCCM), and society of thoracic surgeons (STS) in December 2021","volume":"1","author":"Naidu","year":"2022","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.healun.2022.12.004","article-title":"The 2023 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: a 10- year update","volume":"42","author":"Saeed","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"B19","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/ejcts\/ezw349","article-title":"Novel minimally invasive surgical approach using an external ventricular assist device and extracorporeal membrane oxygenation in refractory cardiogenic shock","volume":"51","author":"Takeda","year":"2017","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1720250\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:44:40Z","timestamp":1778564680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1720250\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":19,"alternative-id":["10.3389\/fcvm.2026.1720250"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1720250","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"article-number":"1720250"}}